Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19 - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Journal of Infectious Diseases Année : 2020

Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19

Laurent Arnaud
Marie Koubi

Résumé

Beside the commonly described pulmonary expression of the coronavirus disease 2019 (COVID-19), major vascular events have been reported. The objective of this study was to investigate whether increased levels of circulating endothelial cells (CECs) might be associated with severe forms of COVID-19. Ninety-nine patients with COVID-19 were enrolled in this retrospective study. Patients in the intensive care units (ICU) had significantly higher CEC counts than non-ICU patients and the extent of endothelial injury was correlated with putative markers of disease severity and inflammatory cytokines. Together, these data provide in vivo evidence that endothelial injury is a key feature of COVID-19.
Fichier principal
Vignette du fichier
jiaa528.pdf (729.98 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03171102 , version 1 (16-03-2021)

Licence

Paternité

Identifiants

Citer

Christophe Guervilly, Stéphane Burtey, Florence Sabatier, Raphaël Cauchois, Guillaume Lano, et al.. Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19. Journal of Infectious Diseases, 2020, 222 (11), pp.1789-1793. ⟨10.1093/infdis/jiaa528⟩. ⟨hal-03171102⟩
127 Consultations
62 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More